40 results
S-3
EX-1.2
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
or is in violation of the U.S. Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (the “FCPA”), the UK Bribery Act … 2010, or any other applicable anti-bribery or anti-corruption law; and (iv) made, offered, authorized, requested, or taken an act in furtherance of any
10-K
2023 FY
EX-10.30
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
the FD&C Act or becoming an article that may not, under the FD&C Act, be introduced into interstate commerce); and
(f)Anti-Bribery and Anti-Corruption … Compliance. Each Party and its Affiliates (i) have complied and shall comply with all Applicable Law governing bribery, money laundering, and other
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
before and after grant of the MA, manufacturing of pharmaceutical products, statutory health insurance, bribery and anti-corruption or with other … the U.K. Bribery Act 2010 (the “Bribery Act”); the U.S. Foreign Corrupt Practices Act (the “FCPA”); and other anti-corruption laws that apply
F-3
EX-1.2
jjqfq2zt07eh 3juzj
5 Aug 21
Shelf registration (foreign)
4:33pm
6-K
EX-10.1
w5r1skmmj
5 Jun 20
Mereo BioPharma Announces Completion of $70 Million Private Placement
12:00am
F-1/A
8mm5e15x bkm1ev8
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
F-1/A
y0oz9jl3bchvprilus
6 Mar 20
Registration statement (foreign) (amended)
5:32pm